Cellaigie
France
unknown
unknown
Stage
About
Cellaigie develops an AI-designed peptide that targets mTOR to induce a cellular state promoting renewal, enhanced clearance, and longevity by biohacking the aging process.
Explore Cellaigie's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.